Therapeutic drug monitoring was helpful in guiding the decision-making process for children receiving infliximab for inflammatory bowel disease

Acta Pediatrica

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2ve51u6
via IFTTT